Dexamethasone Sodium Phosphate Injection
Fresenius Kabi USA, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/08/2019
- Package NDC
- 63323-506-01
- Generic name
- Dexamethasone Sodium Phosphate Injection
- Contact info
- 888-386-1300
- Availability
- Available
- Related info
- Check wholesalers for inventory
- Update date
- 11/03/2026
- Dosage form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)
- Company name
- Fresenius Kabi USA, LLC
- Status
- Current
- Therapeutic category
- Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
- Harmonized identifiers (openFDA)
- Application number
- ANDA040491
- Brand name
- DEXAMETHASONE SODIUM PHOSPHATE
- Generic name
- DEXAMETHASONE SODIUM PHOSPHATE
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 63323-506, 63323-516
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- DEXAMETHASONE SODIUM PHOSPHATE
- RxCUI
- 309696, 1812079
- SPL ID
- 2ce90eb7-067d-4f1c-9184-c250e387e533, 756dda45-ea6d-4c90-a14a-18a78bf186a6
- SPL set ID
- cca2c160-9188-48e8-9505-49a52388dcb7, 7cbd9005-7df2-47ee-adb3-7244c1c69bc3
- Package NDC
- 63323-506-00, 63323-506-01, 63323-506-03, 63323-506-13, 63323-516-01, 63323-516-10, 63323-506-41, 63323-506-16
- UNII
- AI9376Y64P